Program Committee
Continuing Education
Program Agenda
2023 IHA banner 1920x280-72dpi

The International Headache Academy is designed to inspire a long-term commitment to headache medicine in young neurologists and research scientists via an educational program focused on clinical and research aspects of the field.

The American Headache Society is dedicated to mentoring future leaders in headache medicine through both outreach and continued education.

The Ninth IHA will be held January 20-22, 2023 at the UCLA Meyer and Renee Luskin Conference Center in Los Angeles, CA.


The American Headache Society® (AHS) is actively monitoring the health and safety guidance from the Centers for Disease Control as well as state and local health departments. AHS requires attendees to abide by any applicable rules of conduct or local or state laws that may be announced at any time before or during the event, which may include wearing personal protective gear, engaging in social distancing, agreeing to temperature checks or COVID-19 testing requirements, or providing proof of COVID-19 vaccination status. All attendees may have to produce proof of vaccination when you arrive at the meeting.

2023 IHA banner 1920x280-72dpi

IHA Planning and Research Committee Co-Chairs

Elizabeth Leroux, MD
Clinique de la Migraine
Montreal, Quebec

William Renthal, MD, PhD, FAHS
Brigham and Women’s Hospital/Harvard Medical School
Boston, Massachusetts

2023 IHA banner 1920x280-72dpi


At the conclusion of the program, participants will be able to:

  • Identify and describe the role of physiologic structures and systems involved in migraine, cluster headache, and related primary headache conditions
  • Diagnose patients presenting with primary and secondary head pain based on data from history-taking, knowledge of diagnostic criteria, and findings from epidemiologic studies
  • Develop evidence-based treatment plans involving medications/devices, complementary and alternative medicine, and/or behavioral techniques
  • Effectively communicate with headache patients and caregivers, both in eliciting information for history taking and providing information for education
  • Remember the steps involved in conducting a clinical trial and preparing the findings for publication
  • Explain how Headache Medicine can be a rewarding career choice and a viable practice model and evaluate opportunities to enter or advance in the field


The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The American Headache Society® designates this Live activity for a maximum of 10.00 AMA PRA Category 1 Credits.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


  • Attend the sessions in full for which credit is sought
  • Complete the post-activity evaluation
  • A certificate of completion will be available once the evaluation is submitted


The planners and faculty for this activity have no relevant relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.


The American Headache Society gratefully acknowledges the educational grants received for the International Headache Academy from our Industry Supporters:

AbbVie Inc.
Lilly USA, LLC

2023 IHA banner 1920x280-72dpi

2023 International Headache Academy Program Agenda*

*Subject to change

Friday, January 20, 2023
6:00 pm – 7:30 pm Faculty and Delegate Reception
Saturday, January 21, 2023
7:00 am – 8:00 am Continental Breakfast
8:00 am – 8:05 am Welcome and Introduction

Speaker: William Renthal, MD, PhD, FAHS

8:05 am – 8:10 am AHS Presidential Welcome

Speaker: Andrew C. Charles, MD, FAHS

8:10 am – 8:40 am


Keynote Presentation: MABs and Gepants: New Questions, New Answers

Speaker: Jessica Ailani, MD, FAHS

8:40 am – 8:50 am Question and Answer
8:50 am – 9:30 am


Statement for Debate: Neuromodulation for Primary Headache: Are Clinical Results Worth the Cost and Effort

Moderator: Stewart J. Tepper, MD, FAHS


8:50 am – 9:05 am


Delegate: Kendra Pham, MD, MPH


9:05 am – 9:20 am


Delegate: Crystal Jicha, MD


9:20 am – 9:30 am

Question and Answer


9:30 am – 10:00 am



Funding Headache Research


9:30 am – 9:45 am

Additional Funding Opportunities

Speaker: Richard Lipton, MD, FAHS

9:45 am –10:00 am Question and Answer
10:00 am – 10:20 am Special Session: Top Questions the Field Needs to Answer

Speaker: Peter J. Goadsby, MD, PhD, FAHS


10:20 am – 10:30 am Question and Answer
10:30 am – 10:50 am Refreshment Break
10:50 am – 11:20 am Translation of Headache Models into Practice

Speaker: Andrew C. Charles, MD, FAHS


11:20 am – 11:30 am Question and Answer
11:30 am -12:00 pm Clinical Case Presentations: Session 1

Moderator: Amy Gelfand, MD, MAS, FAHS


11:30 am -11:40 am

Red Ear Syndrome

Delegate: Daniel Noam Lax, MD


11:40 am – 11:45 am

Question & Answer


11:45 am – 11:55 am

Paroxysmal Hemicrania in Children

Delegate: Rachel Evans, MD


11:55 am – 12:00 pm

Question & Answer


12:00 pm – 1:00 pm Lunch and Group Photo
1:00 pm – 1:40 pm Keynote Presentation: How and When to Image Headache Patients

Speaker: David Dodick, MD, FAHS

1:40 pm – 1:50 pm Question and Answer
1:50 pm – 2:25 pm






Best Research Basic Science 2022

Moderator: Amynah Pradhan, PhD


1:50 pm – 2:00 pm

The impact of obesity-related raised intracranial pressure in rodents

Delegate: Atlantic D’Souza, MBBS, MRCP


2:00 pm – 2:10 pm

Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice

Delegate: Vimala Bharadwaj, PhD


2:10 pm – 2:20 pm

MNK1/2 contributes to periorbital hypersensitivity and hyperalgesic priming in preclinical migraine models

Delegate: Jhoan Aguilar, BS


2:20 pm – 2:25 pm

Question and Answer

2:25 pm – 2:40 pm Refreshment Break
2:40 pm – 3:30 pm


Special Session: Refractory Patients


2:40 pm – 3:00 pm

Behavioral Approaches: Tricks from the Field

Speaker: Elizabeth Leroux, MD, FRCPC


3:00 pm – 3:20 pm

Pharmacological 3,4th… 10th Line

Speaker: Stephanie Nahas, MD, MSEd, FAHS


3:20 pm – 3:30 pm

Question and Answer

3:30 pm – 4:00 pm Clinical Case Presentations: Session 2

Moderator: Elizabeth Leroux, MD, FRCPC


3:30 pm – 3:40 pm

Migraine Management in Pregnancy

Delegate: Santosh Bhaskarabhatla, MD


3:40 pm – 3:45 pm

Question and Answer


3:45 pm – 3:55 pm

Unmasking CHARGE Syndrome

Delegate: Arthur Washington, MD


3:55 pm – 4:00 pm

Question and Answer


4:00 pm – 4:10 pm Conclusion
6:00 pm – 8:30 pm Faculty and Delegate Dinner


Sunday, January 22, 2023
7:00 am – 7:50 am Continental Breakfast
7:50 am – 7:55 am Introduction and Welcome Back

Elizabeth Leroux, MD, FRCPC

7:55 am – 8:05 am Funding Headache Research

7:55 am – 8:05 am


Speaker: Michael Oshinsky, PhD


8:05 am – 8:10 am Question and Answer
8:10 am – 9:00 am


Research Presentations: Results

Moderator: Robert E. Shapiro, MD, PhD, FAHS


8:10 am – 8:25 am

Acute and Persistent Post-Traumatic Headache-Related Pain in a rodent model: Effect of voluntary exercise

Delegate: Vimala Bharadwaj, PhD


8:25 am – 8:35 am

Question and Answer


8:35 am – 8:50 am

Efficacy and tolerability of anti-CGRP monoclonal antibodies in patients aged ≥65 years with episodic or chronic migraine

Delegate: Sudipa Biswas, MD


8:50 am – 9:00 am

Question and Answer

9:00 am – 9:20 am Advocacy and Headache Medicine

Speaker: Robert E. Shapiro, MD, PhD, FAHS

9:20 am – 9:30 am Question and Answer
9:30 am – 10:10 am


Research Presentations: Proposals

Moderator: William Renthal, MD, PhD, FAHS


9:30 am – 9:45 am

Contribution of intraganglionar S1P-S1PR1 axis to peripheral and central sensitization in a migraine-like model.

Delegate: Ana Salinas-Abarca, PhD


9:45 am -9:50 am

Question and Answer


9:50 am – 10:05 am

Macromastia and Headache: Defining the Headache Prior to Reduction Mammoplasty

Delegate: Kristyn Pocock, MD


10:05 am – 10:10 am

Question and Answer


10:10 am – 10:30 am Refreshment Break
10:30 am – 11:15 am Clinical Case Presentations: Session 3

Moderator: Amaal Starling, MD, MS, FAHS


10:30 am – 10:40 am

Mollaret’s Meningitis

Delegate: Molly Fensterwald, MD


10:40 am – 10:45 am

Question and Answer


10:45 am – 10:55 am


Delegate: Sina Marzoughi, MD


10:55 am – 11:00 am

Question and Answer


11:00 am – 11:10 am

Glossopharyngeal Neuralgia

Delegate: Maksym Marek, MD, MS


11:10 am -11:15 am

Question and Answer


11:15 am – 11:50 am




Best Research Clinical 2022

Moderator: Andrew Charles, MD, FAHS


11:15 am – 11:25 am

Migraine treatment with external concurrent occipital and trigeminal neurostimulation-A randomized controlled trial

Delegate: Aakash Bhargava, MD


11:25 am – 11:35 am

Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial

Delegate: Ankur Banerjee, MD on behalf of Caitlin Christensen, MD


11:35 am – 11:45 am

Psychological disorders, adverse childhood experiences and parental psychiatric disorders in children affected by headache: A systematic review

Delegate: Hannah Shapiro, MD


11:45 am – 11:50 am

Question and Answer


11:50 am – 12:00 pm Conclusion

William Renthal, MD, PhD, FAHS and Elizabeth Leroux, MD, FRCPC


2023 IHA banner 1920x280-72dpi

Candidate Criteria
Interested applicants must be a PGY 3+ Resident, headache medicine fellow, or MD and/or PhD clinician/researcher currently enrolled or within 5 years of having completed their training in the US, Canada, or Latin America. Previous participants of IHA are encouraged to apply should you meet eligibility requirements as outlined.

Application and Supporting Materials
Applicants must complete an online application form and provide the following supporting materials:

  • CV
  • Brief academic update (presentations delivered, abstracts published, manuscripts published or in press, book chapters published or in press, academic promotion, academic appointments, projects funded, or any other update)
  • Letter of support from Department Chair, Program Director, or AHS member
  • A demonstrated interest in headache medicine
  • Completion of statement of interest and financial disclosure form

Applications will be reviewed and rated according to the following:

  • Academic history and productivity
  • Field of study
  • Place of study
  • Quality of research to date (if any)
  • Potential for the applicant to provide leadership in headache medicine and make meaningful contributions to headache research and/or clinical care for many years

Accepted applicants will receive:

Through submission of an optional research proposal, selected applicants may be eligible to receive a $10,000 grant to fund their research project, and those selected will be invited to present at the 66th Annual Scientific Meeting in 2024.

Accepted applicants will also receive a stipend up to $1,500 toward eligible travel expenses and a one-year AHS Trainee membership or a extension of their existing Trainee membership.

Thank you for your interest in the 2023 International Headache Academy. The application period has passed and final recipients will be notified of acceptance on or about Monday, October 17, 2022.

2023 IHA banner 1920x280-72dpi

AHS gratefully acknowledges the educational grant support of the 2023 International Headache Academy from our industry supporters:

AbbVie Inc.
Lilly USA, LLC